MPO and chronic kidney disease: Among individuals with CKD and a mean BMI of 32 kg/m2, elevated plasma MPO was associated with an increased risk of CKD progression (defined as either ≥50% decline in eGFR, the need for kidney replacement therapy [KRT], or eGFR ≤15 mL/min/1.73 m2).37